Related Experiment Videos
A candidate Ross River virus vaccine: preclinical evaluation
1WHO Collaborating Centre for Arbovirus Reference and Research, School of Life Science, Queensland University of Technology, Brisbane, Australia.
Vaccine
|August 1, 1997
Summary
A new killed Ross River virus vaccine shows promise in preventing epidemic polyarthritis. Mouse studies demonstrate effective antibody production and neutralization of the virus, offering hope for a potential human vaccine.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Epidemic polyarthritis, caused by Ross River virus (RRV), affects approximately 5000 Australians annually.
- Symptoms are prolonged (30-40 weeks), with 25% experiencing symptoms for over a year, and no current cure exists.
- Development of an effective RRV vaccine is crucial for public health.
Purpose of the Study:
- To evaluate the immunogenicity of a killed RRV vaccine candidate.
- To assess the neutralizing antibody response and antibody profile in immunized mice.
- To determine the vaccine's efficacy against different RRV strains.
Main Methods:
- Intramuscular (i.m.) immunization of outbred and inbred mouse strains with a 24-hour BEI-inactivated, purified RRV vaccine.
- Analysis of anti-RRV antibody levels and neutralizing capacity.
- Western blot analysis to characterize IgG 2a and IgG 2b antibody responses to RRV proteins.
Main Results:
- All mouse strains produced significant levels of anti-RRV antibody after vaccination.
- Mice receiving two doses of vaccine or live virus showed similar neutralizing antibody levels.
- Distinct differences were observed in IgG 2a and IgG 2b antibody reactions between vaccine and live virus groups.
- Antibodies from BALB/c mice vaccinated with the killed RRV vaccine neutralized all tested RRV strains in vitro.
Conclusions:
- The killed RRV vaccine is immunogenic in mice, inducing significant neutralizing antibody responses.
- The vaccine elicits antibodies capable of neutralizing diverse RRV strains.
- This killed RRV vaccine represents a promising candidate for preventing epidemic polyarthritis.